Vir Biotechnology (VIR) EBT Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -43.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.26 Mn |
| Dec 31, 2025 | 23,969.00 |
| Sep 30, 2025 | -6.80 Mn |
| Jun 30, 2025 | -855,061.00 |
| Mar 31, 2025 | -406,389.00 |
| Dec 31, 2024 | -91,309.00 |
| Sep 30, 2024 | -907,917.00 |
| Jun 30, 2024 | -458,603.00 |
| Mar 31, 2024 | 841,248.00 |
| Dec 31, 2023 | 601,450.00 |
| Sep 30, 2023 | -192,669.00 |
| Jun 30, 2023 | -513,284.00 |
| Mar 31, 2023 | 112,310.00 |
| Dec 31, 2022 | 618,514.00 |
| Sep 30, 2022 | 350,268.00 |
| Jun 30, 2022 | 108,127.00 |
| Mar 31, 2022 | 85,792.00 |
| Dec 31, 2021 | 91,083.00 |
| Sep 30, 2021 | 126,655.00 |